New Treatments for Alzheimers Disease

admin — Thu, 02 Oct 2008 09:23:52 +0000

Dementia is a form of mental decline that causes progressive memory impairment and evils with learning, judgment, communication, and quality of life. The most widespread form of dementia between older people is Alzheimer’s disease (AD), which initially engages the parts of the brain that manage thought, memory, and language. There most likely is not one single cause of Alzheimer’s disease, but quite a few factors that involve each person in a dissimilar way.

Age is the most considerable identified risk factor for AD. The number of people with the illness doubles every 5 years ahead of age 65. Family history is a new risk factor. Scientists consider that genetics may play a role in lots of AD cases. For some people in the early or middle stages of Alzheimer’s disease, convinced medications may lessen some cognitive symptoms or keep the symptoms from getting worse for a limited time.

Treatments for Alzheimer’s Disease

Although there is no treatment for Alzheimer’s disease, planning and medical supervision can help forbearance the burden on both patients and family members. Exercise, good nutrition, behaviors, and social interaction are essential. A calm, structured environment as well may help the person with Alzheimer’s disease to persist functioning as long as possible. No drug treatments can give a cure for Alzheimer’s disease. However, drug treatments have been developed that can recover symptoms, or provisionally slow down their progression, in some people.

There are two main forms of drugs used to care for Alzheimer’s disease. Aricept, Exelon and Reminyl all work in an analogous way, and are identified as acetyl cholinesterase inhibitors. Ebixa works in a dissimilar way to the other three. Behavior management, where carers change behavior by altering the triggers or consequences of the behavior, can be used to decrease depression.

New Drugs used for Alzheimer’s Disease

Razadyne (previously called Reminyl), is one of the newest treatments for Alzheimer’s disease. Razadyne works by defensive the brain’s supply of acetylcholine, a chemical that carries messages among brain cells. Unlike other drugs, Razadyne also look like to raise the production of acetylcholine and makes brain cells more receptive to the chemical.
Exelon (rivastigmine) works by ornamental acetylcholine in the brain. In clinical trials, Exelon vaguely enlarged the memory and thinking skills of several patients with mild to moderate Alzheimer’s disease.
A simple vitamin may seem out of place on this list, but in a few studies vitamin E has exposed promise in Alzheimer’s therapy in recent years.
Namenda (memantine) is the first medication that has been revealed to help people with severe Alzheimer’s disease. It appears to effort by restoring the brain’s balance of glutamate, a chemical that plays a key role in memory and learning.

Information on Alzheimer’s Disease

admin — Tue, 30 Sep 2008 11:19:49 +0000

Alzheimer’s disease (AD) is an age-related, non-reversible brain disorder that develops over a period of years. It is a leisurely progressive disease of the brain that is describe by impairment of memory and eventually by disturbances in reasoning, planning, language, and perception. Dementia arise in people with Alzheimer’s disease because healthy brain tissue degenerates, causing a steady decline in memory and mental abilities.

Many scientists consider that Alzheimer’s disease results as of an increase in the production or growth of a specific protein in the brain that leads to nerve cell death. Alzheimer’s disease is a progressive condition, meaning it will persist to get worse as it develops. Symptoms alter as the condition develops, and it may lead to confusion, personality changes and a total change in behavior. Unfortunately there is no treatment for the condition, although there is treatment accessible that can slow down the development.

Causes of Alzheimer’s Disease

The causes of Alzheimer’s are poorly understood, but its consequence on brain tissue has been demonstrated clearly. Alzheimer’s damages and execute brain cells. Age plays a large part in the growth of Alzheimer’s disease while it is not the only possible cause. It is most frequent in people over the age of 65, affecting around 1 person in 20. The risk raise with age and people over 80 years old are thought to have a 1 in 5 chance of developing the condition.

People among Down’s syndrome are at a higher risk of increasing the Alzheimer’s disease. This is because people among Down’s syndrome have a spare copy of chromosome 21, which enclose a protein that is found in the brain of those with Alzheimer’s disease. Alzheimer’s disease can moreover be inherited, while the risk is only marginally higher than that of someone who has no family history of the condition.

Orientation Tips for Alzheimer’s